H-beta,beta-Diphenyl-DL-Ala-OH is a DL-form, non-proteinogenic amino acid derivative of alanine featuring a β,β-diphenyl substituted backbone that replaces the usual β-methylene position with two phenyl-bearing substituents. The molecule contains a free amino group and a free carboxylic acid, with the side chain functioning as a hydrophobic, aromatic-rich substituent that can influence conformational preferences in peptide-like structures. It is used in peptide chemistry and structure-activity or conformational studies as a defined, stereochemically specified amino acid building block for incorporating bulky diaryl character into synthetic peptides and related analogues.
CAT No: CP27289
CAS No:62653-26-3
Synonyms/Alias:Myristicanhydride;Tetradecanoicanhydride;Myristicacidanhydride;626-29-9;tetradecanoyltetradecanoate;Tetradecanoicacid,anhydride;RCRYHUPTBJZEQS-UHFFFAOYSA-N;Tetradecanoicacid,1,1'-anhydride;myristoylanhydride;AC1L2BQB;AC1Q5XEP;Tetradecanoicanhydride#;ACMC-209n6c;SCHEMBL209749;394580_ALDRICH;CTK5B5411;RCRYHUPTBJZEQS-UHFFFAOYSA-;EINECS210-941-0;ANW-34306;AR-1J6942;MFCD00056151;ZINC71788580;AKOS015950712;AN-25044;LP014221
H-beta,beta-Diphenyl-DL-Ala-OH is a DL-alanine derivative in which the β-carbon bears two phenyl substituents, creating a sterically defined, non-natural β,β-diphenyl motif while retaining the amino acid core with a free carboxylic acid and a free amino group. The molecule is presented as a racemic (DL) mixture, so it contains both stereochemical configurations at the α-chiral center, which can influence peptide coupling behavior and downstream stereochemical outcomes. The presence of an unprotected carboxylic acid and an unprotected amine enables direct acid-base chemistry and coupling-site reactivity, while the hydrophobic diphenyl substitution modulates solubility, conformational preferences, and aromatic π-interactions in assembled peptides or conjugates. As an amino acid-based intermediate, it can be converted into protected derivatives for controlled peptide synthesis and can serve as a chiral or stereochemically defined building block precursor after resolution or stereoselective downstream transformations.
1. Peptide Synthesis
H-beta,beta-Diphenyl-DL-Ala-OH is applied in peptide building block preparation where amino acid coupling chemistry is required, and its α-amino and carboxylic acid functional groups serve as the primary handles for amide bond formation. The β,β-diphenyl substitution introduces bulky hydrophobic character that can be leveraged to tune local sterics and backbone conformational tendencies in peptide sequences. Protected amino acid derivatives derived from this compound can be used in standard peptide coupling workflows, with side-chain phenyl groups remaining as non-reactive aromatic substituents under typical protection/deprotection conditions. Incorporation into peptides can support structure-activity relationship studies and peptidomimetic design by probing how β,β-diaryl substitution affects folding, binding-site complementarity, and proteolytic stability.
2. Peptidomimetics And SAR
H-beta,beta-Diphenyl-DL-Ala-OH is used in peptidomimetic construction for medicinal chemistry research, where non-natural amino acid substitution helps map steric and electronic contributions to molecular recognition. The β,β-diphenyl motif can participate in hydrophobic contacts and π-stacking interactions, while the racemic DL nature enables library synthesis that samples both α-stereochemical configurations for SAR exploration. Conversion to N-protected and C-activated forms supports systematic analog generation, including analogs that vary the position of diaryl substitution while maintaining the alanine-like backbone geometry. Downstream derivatives prepared from this building block can be incorporated into constrained peptide scaffolds or fragment-sized peptidomimetic units to generate structure-defined analog sets for binding and selectivity profiling.
3. Chiral Building Block Development
H-beta,beta-Diphenyl-DL-Ala-OH functions as a chiral amino acid intermediate precursor, because its DL stereochemical composition can be advanced toward enantiopure materials through resolution strategies or stereoselective transformations in later steps. The α-chiral center and the rigid β,β-diphenyl substitution create a stereochemically informative scaffold that can be used to generate defined stereoisomers for stereochemical control in peptide analog synthesis. N-protection of the amino group and activation or esterification of the carboxyl group enable controlled incorporation into stereodefined sequences, while the aromatic substituents remain suitable for later functionalization if desired. Resulting enantiopure derivatives can be applied to stereochemical SAR studies, stereodependent binding investigations, and method development for stereoselective amino acid chemistry.
4. Side-Chain Functionalization
H-beta,beta-Diphenyl-DL-Ala-OH is relevant to side-chain functionalization workflows in synthetic organic chemistry, where the β,β-diphenyl substitution provides an aromatic-rich handle for subsequent derivatization. The compound's free amino and carboxylic acid groups can be protected to allow selective transformations on the aromatic rings or to enable controlled formation of downstream conjugatable intermediates. Aromatic substitution patterns derived from this scaffold can be used to introduce electron-withdrawing or electron-donating groups, enabling tuning of lipophilicity, hydrogen-bonding capacity, and π-interaction strength in peptide-based constructs. Functionalized derivatives can then be used to generate diversified molecular libraries, support chemical biology probes, or serve as intermediates for fine chemical synthesis where diaryl-substituted amino acid motifs are required.
5. Analytical Research Standards
H-beta,beta-Diphenyl-DL-Ala-OH can be employed as an analytical research standard and reference material in amino acid and peptide method development, because its non-natural β,β-diphenyl structure yields distinctive chromatographic and mass spectrometric signatures. The presence of both an amino group and a carboxylic acid enables predictable derivatization behavior for LC-MS or GC-MS workflows, supporting monitoring of protected amino acid intermediates and peptide coupling outcomes. Racemic composition provides a practical reference for assessing stereochemical separation methods when paired with enantiomer-resolving analytical conditions. Downstream protected derivatives and labeled analogs prepared from this scaffold can further support quantitative assays of peptide synthesis intermediates, impurity profiling, and method qualification in applied biochemical research.
6. Pharmaceutical Intermediate Preparation
H-beta,beta-Diphenyl-DL-Ala-OH is suitable for pharmaceutical intermediate preparation in process chemistry contexts, where amino acid derivatives are converted into activated or protected forms for downstream manufacturing of peptide-like intermediates. The amino acid functionality supports formation of N-protected derivatives and carboxyl-activated intermediates that participate in controlled amide bond construction during synthesis of peptidomimetic candidates or peptide fragments. The bulky β,β-diphenyl motif can influence crystallinity, solvation behavior, and impurity profiles, making it relevant to solid-form screening and process route design for synthetic intermediates. Industrially, this scaffold can be incorporated into specialty chemical production streams that require non-natural amino acid building blocks compatible with scalable protection/deprotection logic and coupling-ready intermediate preparation.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.